Evidence map›Paper›PMID 41285033›Full record

ArticleImmunoHorizons2025

Individuals with latent tuberculosis infection display pulmonary airway enrichment and recall recruitment of CD4+ TRM with protective functional phenotypes.

Jessica R Jarvela, Julie G Burel, Michelle Moyer, Bonnie A Thiel, Htin Aung, David H Canaday, Bjoern Peters, Cecilia Lindestam Arlehamn, Richard F Silver

Abstract read
In one paragraph

Article in ImmunoHorizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jessica R JarvelaDivision of Pulmonary, Critical Care and Sleep Medicine, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.
Julie G BurelCenter for Vaccine Innovation, La Jolla Institute for Immunology, University of California San Diego, La Jolla, CA 92037, United States.ORCID 0000-0003-1692-2758
Michelle MoyerDivision of Pulmonary, Critical Care and Sleep Medicine, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.
Bonnie A ThielDivision of Infectious Diseases, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.
Htin AungDivision of Infectious Diseases, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.
David H CanadayDivision of Infectious Diseases, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.
Bjoern PetersCenter for Vaccine Innovation, La Jolla Institute for Immunology, University of California San Diego, La Jolla, CA 92037, United States.
Cecilia Lindestam ArlehamnCenter for Vaccine Innovation, La Jolla Institute for Immunology, University of California San Diego, La Jolla, CA 92037, United States.
Richard F SilverDivision of Pulmonary, Critical Care and Sleep Medicine, Case Western Reserve University School of Medicine and the Louis Stokes Cleveland Department of Veterans' Affairs Medical Center, Cleveland, OH 44106, United States.ORCID 0000-0002-4503-092X

Funding

Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogensU19AI118626 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Bjoern Peters · 2015 to 2026
$36.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Clinical and Translational Science Collaborative (CTSC) of Cleveland UL1TR002548Dahms Clinical Research UnitNCATS NIH HHS UL1 TR002548NIAID NIH HHS U19 AI118626
6 · The paper itself

Abstract

Tuberculosis (TB) remains a worldwide public health threat, in part because of the limited efficacy of current BCG vaccination. Respiratory infection with Mycobacterium tuberculosis (Mtb) is most often followed by the development of protective immunity that contains the pathogen, resulting in latent tuberculosis infection (LTBI). We previously introduced bronchoscopic challenge of LTBI individuals using instillation of purified protein derivative (PPD) of Mtb to model specific induced local recall responses in the human lung. Here, we examined phenotypic and functional aspects of human airway CD4+ T cell populations in LTBI that correlate with protection from Mtb in animal infection models. Baseline bronchoalveolar lavage (BAL) was enriched for CD4+ T cells expressing the KLRG-/CD69+ tissue resident-memory (TRM) phenotype. Both Th1 (CCR6-CCR4-CXCR3+) and Th1* (CCR6+CCR4-CXCR3+) CD4+ T cell subsets demonstrated polyfunctional IFN-γ+TNF-α+ cytokine responses in response to in vitro PPD stimulation. Bronchoscopic PPD challenge, although leading to less robust cellular recruitment than observed previously, preserved the predominance of KLRG1-CD69+ TRM and also of CD4+ T cells that displayed IFN-γ+TNF-α+ dual cytokine production in response to PPD. CD4+ T cells of both control and PPD challenged human lung segments displayed increased expression of the protective CD153 molecule; CD153 expression also correlated with increased cytokine polyfunctionality, particularly of polyfunctional IFN-γ+IL-2+TNF-α+ and IFN-γ+TNF-α+ dual-positive cells. These results support the utility of BAL studies in LTBI to model human correlates of protection from Mtb with potential applicability to the design and initial evaluation of novel approaches to TB vaccination.

Indexed as

CD4-Positive T-LymphocytesImmunologic MemoryLatent TuberculosisLungMycobacterium tuberculosisAdultBronchoalveolar Lavage FluidCytokinesFemaleHumansMaleMiddle AgedPhenotypeTuberculinYoung AdultCytokinesTuberculinbacterial infectionscell traffickinghumanT cellsvaccination

Identifiers

PMID41285033
PMCPMC12643478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.